what is a glp-1 analogue Agonists - it? Comparing Ozempic, Wegovy and Other

Subst Use Misuse 45:17421765 Rentzeperi E, Pegiou S, Koufakis T et al (2022) Sex differences in response to treatment with glucagon-like peptide 1 receptor agonists: opportunities for a tailored approach to diabetes and obesity care

[DOI] [PMC free article] [PubMed] [Google Scholar] [27].Bowden J

P., & Sloan, L

As part of their agreements with CMS, the manufacturers must demonstrate how these lifestyle support programs will meet the program requirements, including encouraging healthy eating and increasing physical activity, supporting medication adherence, ensuring engagement with the program on a regular basis, and ensuring availability of this program to all patients receiving these medications, either online or offline for those who have limited digital access